Hide All

2000 Publications

DELAYED ONSET MUSCLE SORENESS: TREATMENT AND Connolly DAJ, McHugh MP, Sayers SPHuman Performance Laboratory, Department of Physical Education, U. of Vermont, Burlington, VT, Nicholas Institute of Sports Medicine and Athletic Trauma, New York, NY and University of Massachusetts, Amherst, MA. - last modified 2013-02-10 00:00
Colloquium at New England ACSM Nov 3, 2000.


Eccentric exercise has continued to receive attention in recent years as a productive means of exercise. Coupled with eccentric exercise is the heightened interest in the damage that occurs in early stages, commonly referred to as delayed onset muscle soreness (DOMS).

Suggested mechanisms for the treatment of DOMS are numerous and often without any scientific support. It is the objective of this session to firstly review eccentric exercise and its characteristics and then proceed to a scientific overview and evaluation of mechanisms used to treat DOMS. Following a brief introduction Dr. Malachy Mc Hugh, from the Nicholas Institute for Sports Medicine and Athletic

Trauma, will present a session evaluating commonly advocated treatments for DOMS. These will include stretching, cryotherapy, massage and other conventionally used medical rehabilitation techniques.

Following that Dr. Declan Connolly, from the University of Vermont, will present a session evaluating nutritional, supplemental and 'self-treatment' approaches to DOMS. Finally, Mr. Stephen Sayers, a doctoral candidate at the University of Massachusetts Amherst, will present a session evaluating commonly used over the counter and prescription medications for the treatment of DOMS.

This session will focus primarily on anti-inflammatory medications. This symposium will comprise up to date information that advocates much practical information to aid the attendee in understanding both mechanisms for damage and subsequent treatment.

It is our hope that the attendee will leave this session much better able to evaluate both the mechanisms of damage along with the scientifically based therapies for treatment. The session will conclude with a 10-15 minute question and answer session where the audience will have an opportunity to interact directly with the presenters.